Orexigen Therapeutics Mutual Funds

Health Care & Life Sciences » Biotechnology | Orexigen Therapeutics Inc.

Orexigen Therapeutics Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Bridgeway Ultra Small Company Market Fund

49,100

0.26%

12/31/2017

4,655

0.03%

09/05/2018

BlackRock Master Extended Market Index Series

1,808

0.01%

01/31/2018

Rhenman & Partners Fund - Healthcare Equity L/S

-120,000

12/31/2017

AXA/Lord Abbett Micro Cap Portfolio

-1,308

03/31/2018

Illinois State Board of Investment

-2,475

06/30/2016

View Profile

Address	3344 North Torrey Pines Court La Jolla California 92037 United States
Employees	-
Website	http://www.orexigen.com
Updated	09/14/2018
Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities includes recruiting personnel, conducting research and development, including clinical trials, raising capital and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.